Page last updated: 2024-10-30

metformin and Carcinoma, Adenoid Cystic

metformin has been researched along with Carcinoma, Adenoid Cystic in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Carcinoma, Adenoid Cystic: Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lancione, PJ1
Kumar, B1
Zhao, S1
Mroz, EA1
Brock, G1
Rocco, JW1
Carrau, RL1
Agrawal, A1
Seim, N1
Kang, SY1
Ozer, E1
Old, MO1

Other Studies

1 other study available for metformin and Carcinoma, Adenoid Cystic

ArticleYear
A potential protective effect of metformin in adenoid cystic carcinoma.
    Oral oncology, 2020, Volume: 107

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenoid Cystic; Female; Humans; Hypoglycemic Agents; Male

2020
chemdatabank.com